---
up: 
down: 
related: 
tags: []
type:
  - "[[SUB.LO.C.PEX.ANZCA]]"
dg-publish: true
title: 17.2_HaematologicPharmacology
date created: Wednesday, March 5th 2025, 21:03:29
date modified: Tuesday, March 25th 2025, 16:09:21
---

## 17.2 Haematology and Transfusion Pharmacology

This section covers the pharmacological agents that affect haemostasis, coagulation, and fibrinolysis, including anticoagulants, antiplatelet agents, and haemostatic drugs.

### Learning Objectives

- [[ANZCA.17.2.1_BT_PO.1.118_Heparin_LMWH_Pharmacology]]
- [[ANZCA.17.2.2_BT_PO.1.119_Protamine_Pharmacology]]
- [[ANZCA.17.2.3_BT_PO.1.120_Warfarin_Anticoagulants_Pharmacology]]
- [[ANZCA.17.2.4_BT_PO.1.121_Anticoagulant_Effects_Reversal_Methods]]
- [[ANZCA.17.2.5_BT_PO.1.122_Antiplatelet_Drugs_Pharmacology]]
- [[ANZCA.17.2.6_BT_PO.1.123_Thrombolytic_Agents_Pharmacology]]
- [[ANZCA.17.2.7_BT_PO.1.124_Tranexamic_Acid_Pharmacology]]
- [[ANZCA.17.2.8_BT_PO.1.124a_Iron_Replacement_Pharmacology]]
